[Principles for the conservative drug therapy treatment of prostate cancer].
D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002369:Castration; D004359:Drug Therapy, Combination; D045166:Estradiol Congeners / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism; D006801:Humans; D008297:Male; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000378:metabolism; D011467:Prostate / Q000187:drug effects / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D045166:Estradiol Congeners; D004967:Estrogens; D013739:Testosterone; D011388:Prolactin
Grundlagen der konserativ-medikamentösen Behandlung des Prostatakarzinoms.